Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Antiarrhythmic effect of Z-13752A, a dual ACE/NEP inhibitor, is mediated by bradykinin

July 7, 1999

New milrinone analogues exhibit superior inotropic activity and high safety

July 7, 1999

Dual-acting piperazines inhibit TNF-alpha production, stimulate IL-10 production

July 7, 1999

Cell Genesys and Mitotix make progress toward a gene therapy product for restenosis

July 7, 1999

King Pharmaceuticals and Medeva to copromote Altace cardiovascular treatment

July 7, 1999

Novel small-molecule macrophage SR-A antagonist described

July 7, 1999

Phase II testing of promising cardiovascular drug well under way at Merck

July 6, 1999

Animal studies with KC-12792 point to potential of NEP inhibitors in management of heart failure

July 6, 1999

Nesiritide is safe and effective in patients with symptomatic decompensated CHF

July 6, 1999

Phase II ranolazine data published in The American Journal of Cardiology

July 6, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...